These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Adjacent field separation for homogeneous dosage at a given depth; data for the 8 MV (mevatron 8) linear accelerator. Agarwal SK; Marks RD; Constable WC Am J Roentgenol Radium Ther Nucl Med; 1972 Mar; 114(3):623-30. PubMed ID: 4622155 [No Abstract] [Full Text] [Related]
44. 10 MV x-ray beam characteristics from a new 18 MeV linear accelerator. Connor WG; Hicks JA; Boone ML; Mayer EG; Miller RC Int J Radiat Oncol Biol Phys; 1976; 1(7-8):705-12. PubMed ID: 824251 [No Abstract] [Full Text] [Related]
45. Dose rates and field homogeneity of Siemens 42 MeV betatron. Rassow J Acta Radiol Ther Phys Biol; 1969 Aug; 8(4):331-42. PubMed ID: 4981825 [No Abstract] [Full Text] [Related]
46. Field control in roentgen therapy with a 5 MeV linear accelerator by means of television. Malvén R; Rosengren B; Wallman H Acta Radiol Ther Phys Biol; 1968 Dec; 7(6):462-6. PubMed ID: 4980996 [No Abstract] [Full Text] [Related]
47. Use of a solid-state probe to detect changes in operating parameters of an 8 MV linear accelerator. Wright AE; Gager LD; Hudgins PT Radiology; 1972 Oct; 105(1):201-3. PubMed ID: 4626898 [No Abstract] [Full Text] [Related]
48. Design of X-ray targets for high energy linear accelerators in radiotherapy. Podgorsak EB; Rawlinson JA; Glavinović MI; Johns HE Am J Roentgenol Radium Ther Nucl Med; 1974 Aug; 121(4):873-82. PubMed ID: 4215332 [No Abstract] [Full Text] [Related]
49. ENTRANCE AND EXIT ABSORBED DOSE CHARACTERISTICS FOR A 6-MEV X-RAY GENERATOR. CHAMBERLAIN EC; BAILY NA Radiology; 1964 Feb; 82():267-71. PubMed ID: 14115308 [No Abstract] [Full Text] [Related]
50. Lung correction factors for 45-MV x-ray therapy. McGinley PH; Sanders M Med Phys; 1982; 9(5):738-40. PubMed ID: 6818442 [No Abstract] [Full Text] [Related]
51. [DISTANT RADIATION OF THE SKIN WITH X-RAYS IN THE TREATMENT OF MALIGNANT GENERALIZED DERMATOSES]. SCHIRREN CG Actas Dermosifiliogr; 1963 Jun; 54():193-200. PubMed ID: 14078708 [No Abstract] [Full Text] [Related]
52. Output factors and scatter ratios for radiotherapy units. Ahuja AS; Dubuque GL; Hendee WR Phys Med Biol; 1978 Sep; 23(5):968-71. PubMed ID: 101993 [No Abstract] [Full Text] [Related]
53. An easy way of improving the flatness of the radiation from a linear accelerator. Fry WH; Huerta RH; Schirmer MB Acta Radiol Ther Phys Biol; 1973 Oct; 12(5):397-400. PubMed ID: 4204845 [No Abstract] [Full Text] [Related]
54. [Medical data for therapy of a 13MeV linear accelerator--the study of linac therapy. I]. Ozeki M; Ono Y; Noda H; Tsuji Y; Umesaki N Nihon Igaku Hoshasen Gakkai Zasshi; 1969 Feb; 28(11):1465-78. PubMed ID: 4977204 [No Abstract] [Full Text] [Related]
55. Performance of a new 4 MeV standing wave linear accelerator. Sable M; Gunn WG; Penning D; Gardner A Radiology; 1970 Oct; 97(1):169-74. PubMed ID: 5459351 [No Abstract] [Full Text] [Related]
56. [Mechanical construction and performance of 6 MeV medical linear accelerator]. Tatsuno I; Izumi N; Takeda I Nihon Igaku Hoshasen Gakkai Zasshi; 1969 Feb; 28(11):1510-20. PubMed ID: 5253934 [No Abstract] [Full Text] [Related]
57. The significance of screen resolution in treatment verification. Droege RT; Cytacki EP Int J Radiat Oncol Biol Phys; 1982 May; 8(5):873-7. PubMed ID: 6809708 [No Abstract] [Full Text] [Related]